Urban-rural differences in prostate cancer outcomes in Australia: What has changed?

Medical Journal of Australia

Volumn 194, Issue 6, 2011, Pages 293-296

  Baade, Peter D ^a,b   Youlden, Danny R ^a   Coory, Michael D ^c   Gardiner, Robert A ^d   Chambers, Suzanne K ^a,e  

^a VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE CANCER; PROSTATECTOMY; SCREENING TEST; SURVIVAL RATE; SURVIVAL TIME; URBAN RURAL DIFFERENCE;

EID: 79955485634     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb02977.x     Document Type: Article

References (16)

1. Coory MD, Baade PD. Urban-rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia. Med J Aust 2005; 182: 112-115.
2. Armstrong BK, Gillespie JA, Leeder SR, et al. Challenges in health and health care for Australia. Med J Aust 2007; 187: 485-489.
3. Baade PD, Coory MD, Aitken JF. International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 2004; 15: 237-241.
4. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53: 171-184.
5. Australian Bureau of Statistics. Statistical geography Volume 1-Australian Standard Geographical Classification (ASGC). Canberra: ABS, 2006. (ABS Cat. No. 1216.0.)
6. Australian Bureau of Statistics. Population by age and sex-Australian states and territories. Canberra: ABS, 2003. (ABS Cat. No. 3201.0.)
7. Australian Institute of Health and Welfare. Rural, regional and remote health: indicators of health status and determinants of health. (AIHW Cat. No. PHE 97; Rural Health Series No. 9.) Canberra: AIHW, 2008.
8. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-756.
9. Jong KE, Smith DP, Yu XQ, et al. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004; 180: 618-622.
10. Hayen A, Smith DP, Patel MI, et al. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation. Aust N Z J Public Health 2008; 32: 417-420.
11. Baade PD, Aitken JF, Ferguson M, et al. Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities. BMC Cancer 2010; 10: 452.
12. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostatecancer screening trial. N Engl J Med 2009; 360: 1310-1319.
13. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
14. Denham JW, Bender R, Paradice WE. It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials. Med J Aust 2010; 192: 393-396.
15. Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725-732.
16. Etzioni R, Legler JM, Feuer EJ, et al. Cancer surveillance series: interpreting trends in prostate cancer. Part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999; 91: 1033-1039.